These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology - Evolution versus revolution. Burgdorf T; Piersma AH; Landsiedel R; Clewell R; Kleinstreuer N; Oelgeschläger M; Desprez B; Kienhuis A; Bos P; de Vries R; de Wit L; Seidle T; Scheel J; Schönfelder G; van Benthem J; Vinggaard AM; Eskes C; Ezendam J Toxicol In Vitro; 2019 Sep; 59():1-11. PubMed ID: 30946968 [TBL] [Abstract][Full Text] [Related]
63. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities. Maronpot RR Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943 [TBL] [Abstract][Full Text] [Related]
65. Evidence-based toxicology - the toolbox of validation for the 21st century? Hartung T ALTEX; 2010; 27(4):253-63. PubMed ID: 21240468 [TBL] [Abstract][Full Text] [Related]
66. Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis. Péry AR; Schüürmann G; Ciffroy P; Faust M; Backhaus T; Aicher L; Mombelli E; Tebby C; Cronin MT; Tissot S; Andres S; Brignon JM; Frewer L; Georgiou S; Mattas K; Vergnaud JC; Peijnenburg W; Capri E; Marchis A; Wilks MF Sci Total Environ; 2013 Jul; 456-457():307-16. PubMed ID: 23624004 [TBL] [Abstract][Full Text] [Related]
67. Currently available in vitro methods used in the regulatory toxicology. Liebsch M; Spielmann H Toxicol Lett; 2002 Feb; 127(1-3):127-34. PubMed ID: 12052650 [TBL] [Abstract][Full Text] [Related]
68. Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company review. Sparrow SS; Robinson S; Bolam S; Bruce C; Danks A; Everett D; Fulcher S; Hill RE; Palmer H; Scott EW; Chapman KL Regul Toxicol Pharmacol; 2011 Nov; 61(2):222-9. PubMed ID: 21855593 [TBL] [Abstract][Full Text] [Related]
69. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals. Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138 [TBL] [Abstract][Full Text] [Related]
70. Consensus report on the future of animal-free systemic toxicity testing. Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899 [TBL] [Abstract][Full Text] [Related]
71. Use and validation of HT/HC assays to support 21st century toxicity evaluations. Patlewicz G; Simon T; Goyak K; Phillips RD; Rowlands JC; Seidel SD; Becker RA Regul Toxicol Pharmacol; 2013 Mar; 65(2):259-68. PubMed ID: 23291301 [TBL] [Abstract][Full Text] [Related]
72. Food for Thought ... on mapping the human toxome. Hartung T; McBride M ALTEX; 2011; 28(2):83-93. PubMed ID: 21625825 [TBL] [Abstract][Full Text] [Related]
73. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies. Blaauboer BJ Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060 [TBL] [Abstract][Full Text] [Related]
74. The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations. Forster R; Bode G; Ellegaard L; van der Laan JW J Pharmacol Toxicol Methods; 2010; 62(3):236-42. PubMed ID: 20685309 [TBL] [Abstract][Full Text] [Related]
75. Alternative in vitro assays in nanomaterial toxicology. Hartung T; Sabbioni E Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(6):545-73. PubMed ID: 21766468 [TBL] [Abstract][Full Text] [Related]
76. Application of omics data in regulatory toxicology: report of an international BfR expert workshop. Marx-Stoelting P; Braeuning A; Buhrke T; Lampen A; Niemann L; Oelgeschlaeger M; Rieke S; Schmidt F; Heise T; Pfeil R; Solecki R Arch Toxicol; 2015 Nov; 89(11):2177-84. PubMed ID: 26486796 [TBL] [Abstract][Full Text] [Related]
77. Update of the DevTox data database for harmonized risk assessment and alternative methodologies in developmental toxicology: Report of the 9th Berlin Workshop on Developmental Toxicity. Solecki R; Rauch M; Gall A; Buschmann J; Kellner R; Kucheryavenko O; Schmitt A; Delrue N; Li W; Hu J; Fujiwara M; Kuwagata M; Mantovani A; Makris SL; Paumgartten F; Schönfelder G; Schneider S; Vogl S; Kleinstreuer N; Schneider M; Schulze F; Fritsche E; Clark R; Shiota K; Chahoud I Reprod Toxicol; 2019 Oct; 89():124-129. PubMed ID: 31288076 [TBL] [Abstract][Full Text] [Related]
78. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations. Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460 [TBL] [Abstract][Full Text] [Related]
79. Contribution of new technologies to characterization and prediction of adverse effects. Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431 [TBL] [Abstract][Full Text] [Related]
80. Testing and assessment strategies, including alternative and new approaches. Meyer O Toxicol Lett; 2003 Apr; 140-141():21-30. PubMed ID: 12676447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]